SCHEMBL7556041

SCHEMBL7556041

COc1cccc(-c2cncc(-c3cn(CCCN4CCN(C)CC4)c4c(OC)cccc34)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.53
FLT1 P17948 3/20 0.53
FLT4 P35916 3/20 0.53
CNR2 P34972 2/20 0.47
GSK3B P49841 2/20 0.42
BMP4 P12644 1/20 0.42
ABCB1 P08183 3/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
DRD3 P35462 1/20 0.40
SLC6A3 Q01959 1/20 0.40
QPCT Q16769 1/20 0.39
BRD4 O60885 1/20 0.39
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7555367 0.93 KDR (0.51) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7554297 0.92 KDR (0.54) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7556349 0.92 KDR (0.58) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7549301 0.90 KDR (0.52) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7552370 0.88 KDR (0.53) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7990388 0.87 KDR (0.69) KDRFLT1FLT4GSK3BCYP11B1
SCHEMBL7988115 0.87 KDR (0.49) KDRFLT1FLT4CNR2CYP11B1
SCHEMBL7554218 0.87 KDR (0.71) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7976879 0.86 KDR (0.50) KDRFLT1FLT4CNR2GSK3B
SCHEMBL7551662 0.85 KDR (0.59) KDRFLT1FLT4GSK3BBMP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed